FWGIX
Price
$63.63
Change
+$0.33 (+0.52%)
Updated
Dec 20 closing price
TNBRX
Price
$18.66
Change
+$0.12 (+0.65%)
Updated
Dec 20 closing price
Ad is loading...

FWGIX vs TNBRX

Header iconFWGIX vs TNBRX Comparison
Open Charts FWGIX vs TNBRXBanner chart's image
American Funds Capital World Gr&Inc F3
Price$63.63
Change+$0.33 (+0.52%)
VolumeN/A
CapitalizationN/A
1290 SmartBeta Equity R
Price$18.66
Change+$0.12 (+0.65%)
VolumeN/A
CapitalizationN/A
FWGIX vs TNBRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FWGIX vs. TNBRX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWGIX is a Buy and TNBRX is a Hold.

FUNDAMENTALS
Fundamentals
FWGIX has more cash in the bank: 125B vs. TNBRX (217M). FWGIX pays higher dividends than TNBRX: FWGIX (1.99) vs TNBRX (0.92). FWGIX was incepted earlier than TNBRX: FWGIX (8 years) vs TNBRX (10 years). TNBRX is a more actively managed with annual turnover of: 34.00 vs. FWGIX (27.00). TNBRX has a lower initial minimum investment than FWGIX: TNBRX (0) vs FWGIX (1000000). TNBRX annual gain was more profitable for investors over the last year : 14.46 vs. FWGIX (9.01). TNBRX return over 5 years is better than : 41.44 vs. FWGIX (30.17).
FWGIXTNBRXFWGIX / TNBRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years10 years-
Gain YTD8.03513.43360%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets125B217M57,604%
Annual Yield % from dividends1.990.92216%
Returns for 1 year9.0114.4662%
Returns for 3 years7.0215.2346%
Returns for 5 years30.1741.4473%
Returns for 10 yearsN/A97.33-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRON0.960.03
+3.21%
Kronos Bio
NOVT153.500.04
+0.03%
Novanta
ANIK16.31-0.02
-0.12%
Anika Therapeutics
DEO125.47-1.77
-1.39%
Diageo plc
GPCR27.90-2.07
-6.91%
Structure Therapeutics